Hemochromatosis: Genetics helps to define a multifactorial disease

Clinical Genetics

Volumn 54, Issue 1, 1998, Pages 1-9

  Burke, Wylie ^a   Press, Nancy ^b   McDonnell, Sharon M ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; GENE PRODUCT; IRON;

ALCOHOL CONSUMPTION; ANEMIA; ARTHRITIS; AUTOSOMAL RECESSIVE DISORDER; CARDIOMYOPATHY; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENDER; GENE MUTATION; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPOGONADISM; HYPOPITUITARISM; IRON INTAKE; IRON OVERLOAD; LIVER CIRRHOSIS; MULTIFACTORIAL GENETIC DISORDER; PHENOTYPE; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REVIEW;

EID: 0031927156     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb03683.x     Document Type: Review

References (70)

1. Adams PC, Valberg LS. Evolving expression of hereditary hemochromatosis. Semin Liver Dis 1996: 16: 47-54.
2. Niederau C, Fischer R, Purschel A et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996: 110: 1107-1119.
3. Bothwell TH, Charlton RW, Motulsky AG. Hemochromatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic and Molecular Bases of Inherited Disease, Ch. 69, 7th edition. New York: McGraw-Hill, 1995.
4. Bacon BR. Diagnosis and management of hemochromatosis. Gastroenterology 1997: 113: 995-999.
5. Witte DL, Crosby WH, Edwards CQ et al. Practice guideline development task force of the College of American Pathologists. Hereditary Hemochromatosis 1996: 245: 139-200.
6. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis: demonstration of recessive transmission and early detection by family HLA typing. New Engl J Med 1977: 297: 1017-1021.
7. Bernard M, Mura C, Ferec C et al. on behalf of the WHO Nomeclature Committee for Factors of the HLA System. Putting a hold on 'HLA-H'. Nat Genet 1997: 15 (3): 234.
8. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996: 13: 399-408.
9. Fairbanks VF, Baldus WP. Hemochromatosis: the neglected diagnosis. Mayo Clin Proc 1986: 61: 296-298.
10. Edwards CQ, Cartwright GE, Skolnick MH, Amos DB. Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med 1980: 93: 519-525.
11. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991: 90: 445-449.
12. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms and age in 410 hemochromatosis patients. Hepatology 1997: 25: 162-166.
13. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzoni AL et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992: 15: 655-659.
14. Niederau C, Neiderau CM, Lange S, Littauer A, Abdel-Jalia N et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in western Germany. Ann Intern Med 1998: 128: 337-345.
15. Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G. Screening for hemochromatosis: a cost-effectiveness study based on 12258 patients. Gastroenterology 1994: 107: 453-459.
16. Phatak PD, Guzman G, Woll JE et al. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Int Med 1994: 154: 769-776.
17. Edwards CQ, Griffen LM, Goldgar D et al. Prevalence of hemochromatosis among 11065 presumably healthy blood donors. New Engl J Med 1988: 318: 1355-1362.
18. Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30 year database. Gastroenterology 1995: 109: 177-186.
19. Baer DM, Simons JCL, Staples RL, Rumore DJ, Morton CJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995: 98: 464-468.
20. Stohmeyer G, Niederau C, Stremmel W. Survival and causes of death in hemochromatosis: observations in 163 patients. Ann New York Acad Sci. 1988: 526: 245-257.
21. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991: 101: 368-372.
22. Cogswell M, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Iron overload, public health and genetics: evaluating the evidence related to screening for hemochromatosis. Ann Intern Med (Suppl) submitted.
23. Beutler E, Gelbart T, West C et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996: 22: 187-194.
24. Barton JC, Shih WWH, Sawada-Hirai R et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cell Mol Dis 1997: 23: 135-145.
25. Carella M, D'Ambrosio L, Totaro A et al. Mutation analysis of the HFE gene in Italian hemochromatosis patients. Am J Hum Genet 1997: 60: 828-832.
26. Jazwinska EC, Cullen LM, Busfield F et al. Hemochromatosis and HFE. Nat Genet 1996: 13: 399-408.
27. Jouanolle AM, Gandon G, Jezequel P et al. Hemochromatosis and HFE. Nat Genet 1996: 14: 251-252.
28. Borot N, Roth M-P, Malfroy L et al. Mutations in the MHC class 1-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997: 45: 320-324.
29. Adams PC, Chakrabarti S. Genotypic phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria. Gastroenterology 1998: 114: 319-323.
30. Robson KJH, Worwood M, Shearman JD et al. A simple genetic test identifies 90 percent of UK patients with haemochromatosis. Gut 1997: 41: 841-844.
31. Adams PC, Campion ML, Gardon G et al. Clinical and family studies in genetics hemochromatosis: microsatellite and HFE studies in five atypical famlies. Hepatology 1997: 26: 991-995.
32. Feder JN, Tsuchiihashi Z, Irrinki A, Lee VK, Mapa FA et al. The hemochromatosis founder mutation in HLA-H disrupts beta-2-microglobulin interactions and cell surface expression. J Biol Chem 1997: 272: 14025-14028.
33. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z et al. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta-2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci 1997: 94: 12384-12389.
34. Feder JN, Penny DM, Irrinki A, Lee VE, Lebron JA et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci 1998: 95: 1472-1477.
35. Tay JK, Leelayuwat C, Chorney MJ et al. The MHC region contains multiple genes potentially relevant to hemochromatosis. Immunogenetics 1997: 45: 336-340.
36. Edwards CQ, Griffen LM, Kushner JP. The morbidity of hemochromatosis among clinically unselected homozygotes: preliminary report. Adv Exp Med Biol 1994: 356: 303-308.
37. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared to men. Ann Intern Med 1997: 127: 105-110.
38. Conte D, Manachino D, Colli A, Guala A, Aimo G et al. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med 1998: 128: 370-373.
39. Powell LW, Burt MJ, Halliday JW, Jazwinska EC. Hemochromatosis: genetics and pathogenesis. Semin Liver Dis 1996: 16: 55-63.
40. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences amongst homozygous siblings. Hepatology 1996: 23: 724-727.
41. Loreal O, Duegnier Y, Morand R, Lauvin L, Guyader D et al. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron related factors in 127 homozygous patients. J Hepatol 1992: 16: 122-127.
42. Adams PC, Bradley C, Frei JV. Hepatic zinc in hemochromatosis. Clin Invest Med 1991: 141: 16-20.
43. Barton JC, Patton MA, Edwards CQ, Griffen LM, Kushner JP et al. Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med 1994: 124: 193-198.
44. Edwards CQ, Griffen LM, Goldgar DE, Skolnick MH, Kushner JP. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Gastroenterology 1989: 97: 972-981.
45. Seymour DG, Elder GH, Fryer A, Jacobs A, Williams GT. Porphyria cutanea tarda and haemochromatosis: a family study. Gut 1990: 31: 719-721.
46. Kushner JP. The enzymatic defect in porphyria cutanea tarda. New Engl J Med 1982: 306: 799-800.
47. Elder GH, Lee GB, Tovey JA. Decreased activity of hepatic uroporphyinogen decarboxylase in sporadic porphyria cutanea tarda. New Engl J Med 1978: 299: 274-278.
48. Felsher BF, Carpio NM, Egleking DW, Nunn AT. Decreased hepatic uroporphyinogen decarboxylase activity in sporadic porphyria cutanea tarda. New Engl J Med 1982: 306: 766-769.
49. Kushner JP, Barbuto AJ, Lee GR. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyinogen decarboxylase activity. J Clin Invest 1976: 58: 1089-1097.
50. Garey JR, Hansen JL, Harrison LM, Kennedy JB, Kushner JP. A point mutation in the coding region of uroporphyinogen decarboxylase associated with familial porphyria cutanea tarda. Blood 1989: 73: 892-895.
51. Garey JR, Franklin KF, Brown DA, Harrison LM, Metcalf KM, Kushner JP. Analysis of uroporphyinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterology 1993: 105: 165-169.
52. Kappas A, Sassa S, Galbraith RA et al. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Molecular and Metabolic Basis of Inherited Disease, 7th edition. New York: McGraw-Hill, 1995: 2103-3159.
53. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997: 349: 321-323.
54. Santos M, Clevers HC, Marx JJM. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda. New Engl J Med 1997: 336: 1327-1328.
55. Elder GH, Worwood M. Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload. Hepatology 1998: 27: 289-291.
56. Sampietro M, Piperno A, Lupica L, Arosio C, Vergain A, Corbetta N et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998: 27: 181-184.
57. Yaouanq J, Gorsbois B, Jouanelle AM, Goasguen J, Leblay R. Haemochromatosis Cys 282Tyr mutation in pyridoxine-responsive sideroblastic anemia. Lancet 1997: 349: 1475-1476.
58. DeBrakeleer M, St-Pierre C, Vigneault A, Simard H, deMedicis E. Hemochromatosis and pyruvate kinase deficiency. Ann Hematol 1991: 62: 188-189.
59. Conrad ME. Sickle cell disease and hemochromatosis. Am J Hematol 1991: 38: 150-152.
60. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. New Engl J Med 1996: 335: 1799-1805.
61. Hereditary hemochromatosis and its implications: Public workshop sponsored by the Centers for Disease Control and Prevention and the National Human Genome Research Institute, Atlanta GA, March 3-5, 1997.
62. Alper JS, Geller LN, Barash CI et al. Genetic discrimination and screening for hemochromatosis. J Public Health Policy 1994: 15 (3): 345-358.
63. Hudson KL, Rothenberg KH, Andrews LB, Kahn MJE, Collins FS. Genetic discrimination and health insurance: An urgent need for reform. Science 1995: 270: 391-393.
64. Marteau TM. Psychological consequences of cystic fibrosis heterozygote screening. In: Didge JA, Brock DJH, Widdicombe JH, eds. Cystic Fibrosis Current Topics. Chicester: Wiley, 1996: 165-179.
65. Fanos JH, Johnson JP. Perception of carrier status by cysticfibrosis siblings. Am J Hum Genet 1995: 57: 431-438.
66. Browner CH, Press NA. The normalization of prenatal screening: women's acquiescence to the alpha ketoprotein blood test. In: Ginsberg F, Rapp R, eds. Conceiving the New World Order: The Global Politics of Reproduction. Los Angeles: University of CA Press, 1995.
67. Fanos JH, Nickerson BG. Long-term effects of sibling death during adolescence. J Adol Res 1991: 6: 70-82.
68. Bernhardt BA, Chase GA, Faden RR, Geller G, Hofman KJ et al. Educating patients about cystic fibrosis carrier screening in a primary care setting. Arch Family Med 1994: 5: 336-339.
69. Cioffi D. Assymetry of doubts in medical self-diagnosis: the ambiguity if uncertain wellness. J Personal Soc Psych 1991: 61: 969-980.
70. Fanos JH, Johnson JP. Barriers to carrier testing for adult cystic fibrosis sibs: the importance of not knowing. Am J Med Genet 1995: 59: 85-91.